Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fortrea To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in Fortrea between July 3, 2023 and February 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 20, 2025 /PRNewswire/ ...

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, specifically related to the company's financial disclosures and performance claims [1][2]. Company Overview - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions. It was spun off from Labcorp Holdings Inc. in June 2023 and entered into transition services agreements with Labcorp [3]. Allegations - The lawsuit alleges that Fortrea overstated the cost savings and margin improvements expected from exiting the transition services agreements, as well as the revenue from pre-spin projects [4]. Stock Performance - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as previously thought, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 [5]. - On March 3, 2025, Fortrea announced disappointing financial results for Q4 and the full year 2024, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fortrea Holdings, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on August 1, 2025, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - Investors who bought Fortrea securities between July 3, 2023, and February 28, 2025, may be eligible to join a class action lawsuit [1][2]. - A class action lawsuit has already been filed, and interested parties must act by the lead plaintiff deadline to represent other class members [2][4]. - The lawsuit alleges that Fortrea made false and misleading statements regarding its revenue estimates and cost savings, leading to inflated EBITDA targets for 2025 [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen has been recognized as a Titan of Plaintiffs' Bar by Law360, highlighting the firm's expertise in this area [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fortrea Holdings Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its financial prospects and business model during the class period from July 3, 2023, to February 28, 2025 [1]. Allegations - The complaint claims that Fortrea overestimated the revenue contributions from its long-term projects, known as the Pre-Spin Projects, to its 2025 earnings [1]. - It is alleged that Fortrea overstated the cost savings expected from exiting transition services agreements [1]. - The company's previously announced EBITDA targets for 2025 were inflated due to these misrepresentations [1]. - The viability of Fortrea's post-spin-off business model and its financial prospects were also overstated [1]. - Consequently, the company's public statements were materially false and misleading throughout the relevant period [1]. Next Steps for Shareholders - Shareholders who purchased FTRE shares during the specified class period are encouraged to register for the class action by August 1, 2025, to potentially be appointed as lead plaintiff [2]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. - Participation in the case incurs no cost or obligation for the shareholders [2]. About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - A class action lawsuit has been filed against Fortrea Holdings Inc. for alleged violations of the Securities Exchange Act of 1934, specifically regarding misrepresentations about the company's EBITDA targets for 2025 [1][2]. Group 1: Lawsuit Details - The complaint was filed in the United States District Court for the Southern District of New York on behalf of investors who purchased Fortrea securities between July 3, 2023, and February 28, 2025 [1]. - The lawsuit alleges that the company and certain senior officers made misrepresentations concerning the company's financial targets [2]. Group 2: Legal Participation - Investors who wish to serve as lead plaintiffs must file necessary documents by August 1, 2025, although participation as a lead plaintiff is not required to share in any potential recovery [3]. - All legal representation in this case is on a contingency fee basis, meaning shareholders will not incur any fees or expenses [3]. Group 3: Firm Background - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has represented both individual investors and large public and private pension funds [4]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [4].

Core Viewpoint - Fortrea Holdings Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its financial projections and business model [3][4]. Allegations - The complaint claims that Fortrea overestimated revenue contributions from its long-term projects, known as the Pre-Spin Projects, for the year 2025 [3]. - It is alleged that the company overstated potential cost savings from exiting transition services agreements [3]. - The previously announced EBITDA targets for 2025 were inflated as a result of these misstatements [3]. - The viability of Fortrea's post-spin-off business model and its financial prospects were also overstated [3]. - Overall, the company's public statements were materially false and misleading throughout the relevant period [3]. Class Action Details - The class period for the lawsuit is from July 3, 2023, to February 28, 2025 [3]. - Shareholders are encouraged to register for the class action by the deadline of August 1, 2025 [4]. - Participants will be enrolled in a portfolio monitoring software to receive updates on the case [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, following allegations of overstating cost savings and revenue projections related to transition services agreements after its spin-off from Labcorp [1][2][4]. Company Overview - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions. It was spun off from Labcorp Holdings Inc. in June 2023 [3]. Legal Proceedings - The lawsuit is pending in the U.S. District Court for the Southern District of New York, with investors having until August 1, 2025, to seek lead plaintiff status [2]. Allegations - The complaint claims that Fortrea overstated the cost savings and margin improvements expected from exiting transition services agreements, as well as the revenue from pre-spin projects [4]. Stock Performance - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as previously thought, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 [5]. - On March 3, 2025, Fortrea announced disappointing financial results for Q4 and full year 2024, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 [6].

Market Overview - The current Fortrea total addressable market size is over approximately $35 billion[8] - The Pharma & Biotech clinical development spend is over approximately $100 billion[8] - The industry projects a 6-9% long-term CRO market growth and a 3-5% near-term CRO market growth[8] - The industry projects an approximate 4% annual increase in CRO outsourcing rate[8] - Total Pharma R&D spend is projected to increase from $262 billion in 2023E to $302 billion in 2028E[8] Fortrea's Strategy and Operations - Fortrea was formed as an independent, publicly-listed company on July 1, 2023[12] - Fortrea conducts operations in over 90 countries[16] - More than one third of TSAs were exited by December 31st, 2023, with the remainder targeted for exit by December 31st, 2024[27] Quality and Compliance - Fortrea has conducted 797 customer audits and 391 regulatory inspections since 2020[32] - Fortrea has over 129 QA professionals globally, with over 42% having 5+ years tenure with Fortrea[32]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fortrea Holdings, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on August 1, 2025, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - Investors who bought Fortrea securities between July 3, 2023, and February 28, 2025, may be eligible to join a class action lawsuit [1][2]. - A class action lawsuit has already been filed, and interested parties must act by the lead plaintiff deadline to represent other class members [2][6]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. Group 3: Allegations Against Fortrea - The lawsuit alleges that Fortrea made false and misleading statements regarding its revenue projections and cost savings, leading to inflated EBITDA targets for 2025 [4]. - The claims suggest that Fortrea's business model and financial prospects were overstated, resulting in investor damages when the true information became public [4].

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fortrea Holdings Inc. ("Fortrea Holdings Inc." or the "Company") (NASDAQ: FTRE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fortrea Holdings Inc. investors who were adversely affected by alleged securities fraud between July 3, 2023 and February 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/psl ...